100 related articles for article (PubMed ID: 490684)
1. Note on the metabolism of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulfonate.
Gabard B; Walser R
J Toxicol Environ Health; 1979 Jul; 5(4):759-64. PubMed ID: 490684
[TBL] [Abstract][Full Text] [Related]
2. In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.
Stewart JR; Diamond GL
Drug Metab Dispos; 1988; 16(2):189-95. PubMed ID: 2898331
[TBL] [Abstract][Full Text] [Related]
3. Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit.
Maiorino RM; Weber GL; Aposhian HV
Drug Metab Dispos; 1988; 16(3):455-63. PubMed ID: 2900740
[TBL] [Abstract][Full Text] [Related]
4. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate.
Cherian MG; Miles EF; Clarkson TW; Cox C
J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303
[TBL] [Abstract][Full Text] [Related]
5. The effect of 2,3-dimercaptopropane sodium sulfonate on mercury retention in rats in relation to age.
Kostial K; Kargacin B; Blanusa M; Landeka M
Arch Toxicol; 1984 Oct; 55(4):250-2. PubMed ID: 6517703
[TBL] [Abstract][Full Text] [Related]
6. Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.
Maiorino RM; Dart RC; Carter DE; Aposhian HV
J Pharmacol Exp Ther; 1991 Nov; 259(2):808-14. PubMed ID: 1941628
[TBL] [Abstract][Full Text] [Related]
7. The excretion of trace elements in rat urine after treatment with 2,3-dimercaptopropane sodium sulfonate.
Gabard B; Planas-Bohne F; Regula G
Toxicology; 1979; 12(3):281-4. PubMed ID: 494309
[TBL] [Abstract][Full Text] [Related]
8. Removal of internally deposited gold by 2,3-dimercaptopropane sodium sulphonate (Dimaval).
Gabard B
Br J Pharmacol; 1980 Apr; 68(4):607-10. PubMed ID: 7378634
[TBL] [Abstract][Full Text] [Related]
9. Complexing activity and excretion of 2,3-dimercapto-1-propane sulfonate in rat kidney.
Klotzbach JM; Diamond GL
Am J Physiol; 1988 Jun; 254(6 Pt 2):F871-8. PubMed ID: 3381889
[TBL] [Abstract][Full Text] [Related]
10. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.
Diamond GL; Klotzbach JM; Stewart JR
J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658
[TBL] [Abstract][Full Text] [Related]
11. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride.
Gonzalez-Ramirez D; Zuniga-Charles M; Narro-Juarez A; Molina-Recio Y; Hurlbut KM; Dart RC; Aposhian HV
J Pharmacol Exp Ther; 1998 Oct; 287(1):8-12. PubMed ID: 9765315
[TBL] [Abstract][Full Text] [Related]
12. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
13. Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers.
Hurlbut KM; Maiorino RM; Mayersohn M; Dart RC; Bruce DC; Aposhian HV
J Pharmacol Exp Ther; 1994 Feb; 268(2):662-8. PubMed ID: 8113976
[TBL] [Abstract][Full Text] [Related]
14. Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children.
Chisolm JJ; Thomas DJ
J Pharmacol Exp Ther; 1985 Dec; 235(3):665-9. PubMed ID: 4078728
[TBL] [Abstract][Full Text] [Related]
15. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
[TBL] [Abstract][Full Text] [Related]
16. Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. I. Evidence for carrier mediated transport.
Wildenauer DB; Reuther H; Weger N
Chem Biol Interact; 1982 Nov; 42(2):165-77. PubMed ID: 7151227
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of trace elements in humans after sodium 2,3-dimercaptopropane-1-sulfonate challenge test.
Torres-Alanís O; Garza-Ocañas L; Bernal MA; Piñeyro-López A
J Toxicol Clin Toxicol; 2000; 38(7):697-700. PubMed ID: 11192456
[TBL] [Abstract][Full Text] [Related]
18. Chelation of lead by dimercaptopropane sulfonate and a possible diagnostic use.
Twarog T; Cherian MG
Toxicol Appl Pharmacol; 1984 Mar; 72(3):550-6. PubMed ID: 6710504
[TBL] [Abstract][Full Text] [Related]
19. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride.
Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Aposhian MM; Dart RC; Woods JS; Ostrosky-Wegman P; Gonsebatt ME; Aposhian HV
J Pharmacol Exp Ther; 1996 May; 277(2):938-44. PubMed ID: 8627576
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M
Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
